The impacts and implications of virtual consultations in cancer genetics amid the COVID-19 pandemic

FHS
August 4, 2023
10:01 am

Authors assessed the opportunities and challenges brought on by the swift transition to virtual consultations.

Golgi, Breye to develop P2X7 receptor antagonist programme

Diabetic retinopathy is one of the main reasons for blindness among working-age adults. Credit: Alexander Grey from Pixabay. Golgi Neurosciences has joined forces with Breye

July 25, 2023

Eli Lilly concludes Morphic acquisition for IBD portfolio expansion

The acquisition will aid Lilly in enhancing treatment options for individuals suffering from IBD. Credit: Tada Images/Shutterstock. Eli Lilly and Company has concluded the acquisition

August 19, 2024

Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy

Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body’s own immune system to fight a tumor.

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.